The Recall Desk
ModerateFDA (Drugs)·D-0092-2021·Announced 2020-11-25

Milbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations

Milbar Laboratories is voluntarily recalling 4,855 tubes of Willa Clear Skin (Salicylic Acid 2%) due to Good Manufacturing Practice (GMP) deviations. The product was distributed nationwide and internationally.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically involves a reasonable probability of temporary or medically reversible health consequences. The source cites GMP deviations without reporting specific injuries or illnesses, aligning with a Moderate severity rating for a voluntary precautionary recall.

Plain-English summary

Milbar Laboratories, Inc. is voluntarily recalling 4,855 tubes of Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes. The recall was initiated on October 9, 2020, and was classified as Class II by the FDA. The reason for the recall is Good Manufacturing Practice (GMP) deviations.

The affected product is identified by Lot # DW827-4 and an expiration date of Mar-22. The product was distributed throughout the United States, including Puerto Rico, and internationally. The recall was initiated by the firm and was terminated on January 4, 2023.

Consumers with this product should stop using it and follow the instructions provided by the recalling firm or the FDA. The recall was initiated via letter notification to initial firms.

The recalled product

Product
Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist. Chandler, AZ 85226
Manufacturer
Milbar Laboratories, Inc.
Category
Drug — Topical Dermatology
Hazard
Affected units
4,855

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: DW827-4
  • Exp. Date Mar-22

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 14 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →

Related recalls

Same manufacturer · Milbar Laboratories, Inc.

See all →

Same hazard · gmp deviation

See all →